Maternal Mental Health - Market Insights, Competitive Landscape, and Market Forecast - 2030

Maternal Mental Health Market By Indication (Postpartum Depression And Depressive Disorders), Treatment (Psychotherapy And Antidepressants), And Geography (North America, Europe, Asia-Pacific, And Rest Of The World) are expected to grow at a steady cagr forecast till 2030 owing to the rising prevalence of maternal mental health disorders, increasing awareness of maternal mental health issues, and growing innovations in technology across the globe.

The global maternal mental health market is estimated to grow at a CAGR of 14.57% during the forecast period from 2024 to 2030. The demand for maternal mental health is primarily being boosted by the growing prevalence of maternal mental health disorders such as postpartum depression, dysthymia, pregnancy-related anxiety, birth-related PTSD (Post-traumatic stress disorder), and others. Furthermore, the growing awareness regarding maternal mental health issues and increasing regulatory approvals for various therapies associated with maternal mental health are also driving the market. Additionally, the growing number of innovations in technology such as the integration of telehealth, mobile apps, and digital health platforms with maternal mental health solutions are some of the other key factors that are responsible for contributing to the positive growth of the maternal mental health market during the forecast period from 2024 to 2030.

Maternal Mental Health Market Dynamics:

According to the recent updates provided by the World Health Organization (WHO), (2022), globally 1 in 5 women experience mental health problems during pregnancy or postpartum, with 20% having suicidal thoughts or self-harming. Thus, by addressing the critical issues of maternal mental health, it is concluded that it requires a multi-faceted approach involving integrated healthcare services, technological solutions, community support systems, policy initiatives, and culturally sensitive interventions in order to address such disorders. Thus, increasing prevalence of mental health disorders will positively contribute to the market growth of maternal mental health market.

Additionally, as per the estimates, postpartum depression (PPD), affects 10-15% of women worldwide, and is the most prevalent non-psychotic complication following childbirth. This anticipated surge in postpartum depression cases is likely to drive the demand for the maternal mental health market as more women and healthcare providers recognize the symptoms of PPD, the demand for mental health services, including therapy, counseling, and support groups, will also increase, leading to the positive market growth of the maternal mental health.

Additionally, the increased awareness programs can lead to the formation of more support groups and community-based programs that provide emotional and practical support to new mothers thereby increasing the market demand for maternal mental health. For instance, in September 2022, the World Health Organization provided the guide which includes the integration of perinatal mental health in maternal and child health services which outlines an evidence-informed strategies for program managers, health administrators, and policy-makers to develop and maintain high-quality mental health services for women during the perinatal period. The guide support providers in promoting good mental health, identifying symptoms of mental health issues, and responding appropriately within local and cultural contexts.

Additionally, the recent product approvals in the domain of maternal mental health are anticipated to boost the market of maternal mental health. For instance, in August 2023, FDA approved Zurzuvae (zuranolone), the first oral medication indicated to treat postpartum depression (PPD). Thus, these factors are collectively responsible for boosting the market, ensuring better support and care for mothers experiencing mental health challenges during the perinatal period.

However, the side effects of antidepressants, such as nausea, fatigue, weight gain, and sexual dysfunction, can be particularly challenging for new mothers and lack of accessibility and availability of mental health professionals in some regions across the globe may hinder the market demand of maternal mental health.

Maternal Mental Health Market Segment Analysis:

Maternal Mental Health Market by Indication (Postpartum Depression and Depressive Disorders), Treatment (Psychotherapy and Antidepressants), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the indication segment of the maternal mental health market, postpartum depression is estimated to have a significant revenue share in the maternal mental health market in 2023. Increased recognition of PPD as a serious and common condition has led to greater public and healthcare provider awareness. Campaigns and advocacy efforts have highlighted the prevalence and impact of PPD, encouraging more women to seek help. As more women and their families recognize the signs of PPD, the demand for mental health services, including therapy, counseling, and psychiatric care, has risen. Growing awareness of PPD has led to policy changes that mandate screening and treatment for maternal mental health issues during prenatal and postnatal care. This integration into standard healthcare practices has expanded the market for related services and products.

Additionally, the growing prevalence of postpartum depression has boosted the market for maternal mental health. According to the recent data provided by the organization named Postpartum Depression, states that in 2019 approximately 23% of Canadian mothers experienced the symptoms of postpartum depression and anxiety post-delivery. Furthermore, young mothers at the age 25 or below were more likely to develop postpartum depression.. Thus, the rise in the prevalence of postpartum depression will eventually boost the revenue share for this segment, this in return boosting the overall market of maternal mental health.

Moreover, the rising regulatory approvals and increased innovations such as the integration of telemedicine, and digitalization with postpartum depression solutions will also contribute to the growth of the maternal mental health market. For instance, in April 2022, Vital Start Health, a University of Pennsylvania startup and Microsoft for Startups member launched COURAGETM, a next-generation, multi-lingual platform offering comprehensive coaching and psychotherapy for maternal well-being throughout pre-pregnancy, pregnancy, and postpartum stages.

Hence, all the factors mentioned above are promoting the overall market growth of maternal mental health during the forecast period.

North America Is Expected To Dominate The Overall Maternal Mental Health Market:

North America is expected to account for the highest proportion of the maternal mental health market in 2023, out of all regions. This domination is due to the increasing cases of maternal mental health disorders, postpartum depression, and other stress and anxiety-related conditions in the region. Additionally, increasing regulatory approvals, increasing awareness programs, and product launch activities are expected to aid in the growth of the North America maternal mental health market during the forecast period of 2024 to 2030.

As per the estimates, the total diagnosed prevalent maternal postpartum depression (PPD) cases in the United States were nearly 716,000 which is projected to increase during the forecast period.

According to the recent facts provided by the Policy Centre for Maternal Mental Health United States, in 2023, approximately 96% of birthing-aged women live in areas with a shortage of maternal mental health professionals. 70% of counties lack sufficient maternal mental health resources, with nearly 700 counties at high risk for maternal mental health disorders and over 150 counties are in the "Maternal Mental Health Dark Zone," characterized by both high risk and significant resource gaps. Hence, the lack of adequate maternal health solutions in some regions is a significant driver for the future market of maternal mental health. This gap creates opportunities for new market entrants, allowing them to innovate and capture market share by addressing unmet needs and leveraging emerging trends.

Another factor responsible for the growth of the maternal mental health market is the rising regulatory product approvals. For instance, on April, 2024, Curio’s MamaLift Plus™, the first digital therapeutic for maternal mental health was approved by FDA.

Additionally, the continuous awareness program in the United States related to maternal mental is also driving the market of maternal mental health in the region. For instance, in February 2024, the U.S. Department of Health and Human Services, along with leaders from across HHS, met with state leaders and representatives from the National Governors Association (NGA) to announce the launch of the HHS Secretary's Postpartum Maternal Health Collaborative, aimed at improving maternal and child health in rural America.

Thus, the above mentioned factors are responsible for driving the demand of maternal mental health in the North America market.

Maternal Mental Health Market Key Players:

Some of the key market players operating in the maternal mental health include Biogen Inc., Sage Therapeutics, Inc., Therapy Mama., Canopie., Postpartum Support International, SonderMind Inc., Maven Clinic Co., Wildflower Health, Hims & Hers Health, Inc., Medela, Bausch Health Companies Inc., Maternal Mental Health Alliance, MumsAid, Cedars-Sinai, Marinus Pharmaceuticals, Brii Biosciences Limited, and others.

Recent Developmental Activities In The Maternal Mental Health Market:

• In December 2023, Centers for Medicare & Medicaid Services announced the new Transforming Maternal Health (TMaH) Model. The model will include access to care, infrastructure, and workforce capacity, quality improvement and safety, and whole-person care delivery.
• In August 2023, American Psychiatric Association released New Educational Resources on Maternal Mental Health. It consist of a toolkit includes eight fact sheets for clinicians and patients, a white paper and a four-part webinar series covering this understudied and underserved area of mental health.s
• In September 2022, Lipocine Inc. announced a favorable regulatory pathway on oral LPCN 1154 for postpartum depression

Key Takeaways From The Maternal Mental Health Market Report Study

• Market size analysis for current maternal mental health market size (2023), and market forecast for 6 years (2024 to 2030).
• Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years.
• Key companies dominating the global maternal mental health market.
• Various opportunities available for the other competitors in the maternal mental health market space.
• What are the top-performing segments in 2023? How these segments will perform in 2030?
• Which are the top-performing regions and countries in the current maternal mental health market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for maternal mental health market growth in the coming future?

Target Audience Who Can Be Benefited From This Maternal Mental Health Market Report Study

• Maternal mental health product providers.
• Research organizations and consulting companies.
• Maternal mental health-related organizations, associations, forums, and other alliances.
• Government and corporate offices.
• Start-up companies, venture capitalists, and private equity firms.
• Distributors and Traders dealing in maternal mental health.
• Various end-users who want to know more about the maternal mental health market and the latest technological developments in the maternal mental health market.

Frequently Asked Questions For The Maternal Mental Health Market:

1. What is maternal mental health?

Maternal mental health refers to the psychological and emotional well-being of women during pregnancy, childbirth, and the postpartum period. It encompasses a range of mental health conditions that can affect women during these stages of pregnancy.

2. What is the market for maternal mental health?

The global maternal mental health market is estimated to grow at a CAGR of 14.57% during the forecast period from 2024 to 2030.

3. What are the drivers for the global maternal mental health market?

The demand for maternal mental health is primarily being boosted by the growing prevalence of maternal mental health disorders such as postpartum depression, dysthymia, pregnancy-related anxiety, birth-related PTSD (Post-traumatic stress disorder), and others. Furthermore, the growing awareness regarding maternal mental health issues and increasing regulatory approvals for various therapies associated with maternal mental health are also driving the market. Additionally, the growing number of innovations in technology such as the integration of telehealth, mobile apps, and digital health platforms with maternal mental health solutions are some of the other key factors that are responsible for contributing to the positive growth of the maternal mental health market during the forecast period from 2024 to 2030.

4. Who are the key players operating in the global maternal mental health market?

Some of the key market players operating in the maternal mental health include Biogen Inc., Sage Therapeutics, Inc., Therapy Mama., Canopie., Postpartum Support International, SonderMind Inc., Maven Clinic Co., Wildflower Health, Hims & Hers Health, Inc., Medela, Bausch Health Companies Inc., Maternal Mental Health Alliance, MumsAid, Cedars-Sinai, Marinus Pharmaceuticals, Brii Biosciences Limited, and others.

5. Which region has the highest share in the global maternal mental health market?

North America is expected to account for the highest proportion of the maternal mental health market in 2023, out of all regions. This domination is due to the increasing cases of maternal mental health disorders, postpartum depression, and other stress and anxiety-related conditions in the region. Additionally, increasing regulatory approvals, increasing awareness programs, and product launch activities are expected to aid in the growth of the North America for maternal mental health market during the forecast period of 2024 to 2030.


This product will be delivered within 2 business days.